Longitudinal investigation of ovarian aging- the impact of PFAS
Active Grant Awarded
- Award ID
- RES038150U1VBD9
- Recipient
-
Icahn School Of Medicine At Mount Sinai UEI C8H9CNG1VBD9
- Awarding agency
-
National Institute of Environmental Health Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $830,657
Award facts
- Assistance listing
- 93.ESR Environmental Health Sciences - Research Projects
- Completion date 1% complete
- Place of performance
- New York, NY 10029, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded Icahn School of Medicine at Mount Sinai a grant with $830,657 obligated on Oct 29, 2026, under the Environmental Health Sciences - Research Projects program (CFDA 93.ESR). The award runs through Oct 31, 2031, with performance in New York, NY 10029.
The funded work is a longitudinal investigation of how per- and polyfluoroalkyl substance (PFAS) exposures affect ovarian reserve decline. It uses the MAMAS PROGRESS cohort to study exposures across a 15-year reproductive window (ages 28 to 45). The study applies hybrid targeted and non-targeted liquid chromatography high-resolution mass spectrometry (LC-HRMS) to profile thousands of PFAS chemicals and endogenous endocrine metabolites. Aim 1 defines the integrated PFAS-ome by characterizing temporal exposure patterns, calculating PFAS burden scores, and evaluating how lactation, pregnancy, and menopause staging affect PFAS levels. Aim 2 determines how ovarian decline, measured via anti-Müllerian hormone (AMH) levels, relates to these exposures.
The program funds research projects that develop technologies to assess human environmental exposures, study their biological mechanisms, and conduct epidemiological studies of health effects.
Description
- Abstract
- Early menopause (< 45 years) increases risks of osteoporosis, cardiovascular disease, and degenerative disorders, including cognitive decline and metabolic syndrome, whilelate menopause (> 55 years) increasestherisk of breast and endometrial cancer. While this points to the natural depletion of ovarian follicles (i.e., ovarian reserve) as a critical primary outcome of women's reproductive health, ovarian reserve decline has largely been ignored as a target to promote healthy aging in women. Despite evidence that environmental exposures such as per- and polyfluoroalkyl substances (PFAS) alter ovarian reserve, affect fertility, cause irregularities in menstrual cycle, and promote early or late menopause, how PFAS influence ovarian reserve remains poorly understood. Further, traditional approaches to PFAS research measure a limited subset of chemicals, failing to capture the breadth and complexity of the thousands of industrially released PFAS chemicals (i.e., the "PFAS-OME"). Therefore, this study leverages the maternal mexicans programming research in obesity, growth, environment, and social stressors (mamas progress) cohort to investigate the longitudinal relationship between PFAS-OME exposures and ovarian reserve decline. Over a 15-year reproductive window (ages 28-45), we will utilize state-of-the-art hybrid targeted/non-targeted liquid chromatography high-resolution mass spectrometry (LC-HRMS) to profile thousands of PFAS chemicals and endogenous endocrine metabolites. In aim 1, we will define the integrated PFAS-OME across a reproductive decade (from the average age of 28 to 45) by characterizing temporal exposure patterns, calculating PFAS burden scores (an aggregate PFAS exposure metric), and evaluating the effect of excretion factors such as lactation, pregnancy, and menopause staging on PFAS levels. Aim 2 will determine how ovarian decline, measured via anti-mullerian hormone (AMH) levels, is affected by individual PFAS chemicals and mixtures, identifying critical timing for intervention. Aim 3 will define the endocrine metabolome of PFAS by identifying bile acids, hormones, and other steroids associated with PFAS exposure, as well as the endocrine pathways that mediate associations between PFAS and AMH. We will also develop precision health risk prediction models. This research will provide critical data on how ovarian aging is affected by one of the most prevalent toxic environmental exposures, PFAS. We will identify high-risk women before menopause and lay the foundation for future precision environmental health strategies to screen at-risk women to reduce the subsequent downstream adverse health risks from altered menopause timing.
Quick answers
Who received award RES038150U1VBD9?
RES038150U1VBD9 was awarded to Icahn School Of Medicine At Mount Sinai by National Institute of Environmental Health Sciences (National Institutes of Health) on October 29, 2026.
How much is award RES038150U1VBD9 worth?
$830,657 has been obligated on RES038150U1VBD9.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award